Will New Anti-eosinophilic Drugs Be Useful in Asthma Management?

Recently there has been great interest in the development of precision medicines that target a specific underlying disease mechanism so that responders will have a better therapeutic response and less adverse effects compared with the nonspecific therapies that are currently used. Peter Barnes is Professor of Thoracic Medicine and Head of Respiratory Medicine at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London.

 

Publication

Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Targeting cytokines to treat asthma and chronic obstructive pulmonary disease

Next Article

Exploring professional development for older workers in the higher education workplace

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×